SCHEMBL7779590

SCHEMBL7779590

CC=Cn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(C)cc2)c1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.47
CA9 Q16790 15/20 0.46
CA12 O43570 12/20 0.46
CA2 P00918 9/20 0.46
CA1 P00915 8/20 0.46
CA4 P22748 3/20 0.46
PTGS2 P35354 3/20 0.41
CYP2C9 P11712 1/20 0.41
PTPN7 P35236 1/20 0.40
MT-CO2 P00403 1/20 0.40
LMNA P02545 1/20 0.40
CA3 P07451 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA2B P18089 1/20 0.40
PTGS1 P23219 1/20 0.40
CA6 P23280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777224 0.90 PTGS2 (0.47) CA9CA12CA2CA1CA4
SCHEMBL7780439 0.90 PTGS2 (0.48) CA9CA12PTGS2PTGS1
SCHEMBL7780023 0.85 CA9 (0.45) CA9CA12CA2CA1CA4
SCHEMBL8166784 0.82 KMT2A (0.52) KMT2ACA9CA12CA2CA1
SCHEMBL7779817 0.82 CA9 (0.48) CA9CA12CA2CA1CA4
SCHEMBL7773221 0.81 PTGS2 (0.49) PTGS2PTGS1
SCHEMBL7773256 0.80 PTGS2 (0.54) CA9CA12CA2CA1CA4
SCHEMBL7777559 0.80 PTGS2 (0.48) CA9CA12CA2CA1CA4
SCHEMBL7777655 0.80 PTGS2 (0.46) CA9CA12CA2CA1CA4
SCHEMBL8634798 0.80 PTGS1 (0.42) CA9CA12PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed